Immortal Dragons Backs Frontier Bio: Advancing 3D Biofabrication for Tissue Engineering
Summary
Immortal Dragons announced a strategic investment in Frontier Bio, a biotechnology company focused on 3D biofabrication and tissue engineering. Frontier Bio develops tissue-engineered blood vessels, organ-on-a-chip models, and 3D bioprinted tissues designed to improve pre-clinical testing and address unmet medical needs. The company says its vascular grafts have shown strong results in large animal studies, including no thrombosis or infection after implantation. The investment supports Frontier Bio’s broader goal of manufacturing organs and tissues on demand for longevity and replacement medicine applications.
Funding
Amount
-
Total raised
Date
August 29, 2025
Announcement date
Investors
-
Lead investors
Company
https://www.frontierbio.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected